Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGENOMICS INCNEO · Entity 2096 | Director | January 07, 2021 | January 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGENOMICS INC
Report date January 07, 2021 · Filed January 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Aspen Select Opportunity Fund | 1,100,000 |
Reported balance
After 2021-01-07 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-01-07 · Exercise / conversion · Acquired 100,000 · Balance 1,100,000 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| Common StockSEC Table I · non-derivative | Direct | 90,218 |
Ending reported balance
After 2021-01-07 transaction · row 7
3 source rows · reconciled sequenceRow 5 · 2021-01-07 · Exercise / conversion · Acquired 10,000 · Balance 82,932 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Row 6 · 2021-01-07 · Exercise / conversion · Acquired 3,017 · Balance 85,949 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Row 7 · 2021-01-07 · Exercise / conversion · Acquired 4,269 · Balance 90,218 F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.15 · Expires 2021-04-20 | IndirectBy Aspen Select Opportunity Fund | 0 |
Reported balance
After 2021-01-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-01-07 · Exercise / conversion · Disposed 100,000 · Balance 0 F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP. F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.27 · Expires 2022-05-25 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-01-07 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.60 · Expires 2023-06-01 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-01-07 · Exercise / conversion · Disposed 3,017 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.52 · Expires 2026-06-06 | Direct | 0 |
Reported balance
After 2021-01-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-01-07 · Exercise / conversion · Disposed 4,269 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.54 · Expires 2027-05-28 | Direct | 3,448 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 3,448 |
| Common StockSEC Table I · non-derivative | IndirectBy self as Trustee for Steven and Carisa Jones 401k and Trust | 125,000 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 125,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Jones Network, LP | 30,476 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,476 |
| Common StockSEC Table I · non-derivative | IndirectShares owned in IRA, custodian accounts, and trusts for the family of Steven Jones | 40,757 |
Reported balance
Holding disclosure · report date 2021-01-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 40,757 |
Filing footnotes · ownership attribution and instrument terms
F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC.
F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP.
F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,269 | $0.00 Strike: $22.52 | $0.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · derivative · entry 11 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,269 shares Expires 2026-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,017 | $0.00 Strike: $11.60 | $0.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,017 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · derivative · entry 9 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · derivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 4,269 | $22.52 | $96,137.88 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 3,017 | $11.60 | $34,997.20 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 10,000 | $7.27 | $72,700.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:24 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 100,000 | $7.15 | $715,000.00 |
DisclosureSEC source: 0001077183-21-000053 · wf-form4_161040387992653.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC. F2 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 14, 2020 Filed Dec 14, 2020 22:49 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 25,000 | $51.67 | $1,291,750.00 |
DisclosureSEC source: 0001077183-20-000225 · wf-form4_160798614957845.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,000,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:49 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 25,000 | $50.52 | $1,263,000.00 |
DisclosureSEC source: 0001077183-20-000225 · wf-form4_160798614957845.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,025,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:49 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 20,000 | $50.30 | $1,006,000.00 |
DisclosureSEC source: 0001077183-20-000225 · wf-form4_160798614957845.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,050,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 07, 2020 Filed Dec 7, 2020 23:23 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 45,658 | $49.45 | $2,257,788.10 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,070,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 23:23 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 64,394 | $48.07 | $3,095,419.58 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,115,658 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 23:23 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 19,948 | $48.03 | $958,102.44 |
DisclosureSEC source: 0001077183-20-000221 · wf-form4_160738336847250.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,180,052 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,932 Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 81,000 | $36.55 | $2,960,550.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,932 Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 141,049 | $36.95 | $5,211,760.55 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,200,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 19,000 | $36.56 | $694,640.00 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,932 Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 22:25 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 38,951 | $36.34 | $1,415,479.34 |
DisclosureSEC source: 0001077183-20-000189 · wf-form4_160150468792948.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,341,049 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 22:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 37,991 | $37.13 | $1,410,605.83 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,380,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 22:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 71,583 | $36.98 | $2,647,139.34 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,417,991 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 22:16 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 10,426 | $36.13 | $376,691.38 |
DisclosureSEC source: 0001077183-20-000185 · wf-form4_159977617760663.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,489,574 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000129 · wf-form4_159105214951321.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000129 · wf-form4_159105214951321.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,932 Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 22:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000049 · wf-form4_158439873738000.xml · derivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 22:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 125,000 | $4.78 | $597,500.00 |
DisclosureSEC source: 0001077183-20-000049 · wf-form4_158439873738000.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 20,000 | $28.24 | $564,800.00 |
DisclosureSEC source: 0001077183-20-000045 · wf-form4_158336742702577.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Jones Network, LP Disclosed balance after: 30,476 Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 2,300 | $28.24 | $64,952.00 |
DisclosureSEC source: 0001077183-20-000045 · wf-form4_158336742702577.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 40,757 Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 25,000 | $28.48 | $712,000.00 |
DisclosureSEC source: 0001077183-20-000045 · wf-form4_158336742702577.xml · nonDerivative · entry 2 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By self as Trustee for Steven and Carisa Jones 401k and Trust Disclosed balance after: 125,000 Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 250,000 | $28.85 | $7,212,500.00 |
DisclosureSEC source: 0001077183-20-000045 · wf-form4_158336742702577.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,375,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2021-04-20 F2 · kind: On December 30, 2019, Mr. Jones transferred this option to Aspen Select Opportunity Fund, LP as part of estate planning activities. F4 · derivative.exercise_date: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · derivative · entry 9 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2021-04-20 F2 · kind: On December 30, 2019, Mr. Jones transferred this option to Aspen Select Opportunity Fund, LP as part of estate planning activities. F4 · derivative.exercise_date: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · derivative · entry 8 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 125,000 Underlying: Common Stock · 100,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · derivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2020-05-04 F2 · kind: On December 30, 2019, Mr. Jones transferred this option to Aspen Select Opportunity Fund, LP as part of estate planning activities. F3 · derivative.exercise_date: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | OtherStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · derivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 225,000 shares Expires 2020-05-04 F2 · kind: On December 30, 2019, Mr. Jones transferred this option to Aspen Select Opportunity Fund, LP as part of estate planning activities. F3 · derivative.exercise_date: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 23:45 UTC | NEOGENOMICS INC NEO · Entity 2096 | Exercise / conversionCommon Stock | 100,000 | $4.78 | $478,000.00 |
DisclosureSEC source: 0001077183-20-000003 · wf-form4_157800868815371.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,625,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 22:35 UTC | NEOGENOMICS INC NEO · Entity 2096 | GiftCommon Stock | 50,000 | $24.53 | $1,226,500.00 |
DisclosureSEC source: 0001077183-19-000220 · wf-form4_157446213009752.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,234 Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 22:35 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 23,162 | $24.27 | $562,141.74 |
DisclosureSEC source: 0001077183-19-000220 · wf-form4_157446213009752.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,525,000 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 22:35 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 128,068 | $24.35 | $3,118,455.80 |
DisclosureSEC source: 0001077183-19-000220 · wf-form4_157446213009752.xml · nonDerivative · entry 3 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,548,162 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 00:32 UTC | NEOGENOMICS INC NEO · Entity 2096 | GiftCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 43,057 Read SEC document |
| September 10, 2019 Filed Sep 11, 2019 00:32 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,200 | $21.47 | $25,764.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones Disclosed balance after: 46,457 Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 00:32 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 3 | $25.00 | $75.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,676,230 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| September 06, 2019 Filed Sep 11, 2019 00:32 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,691 | $25.00 | $42,275.00 |
DisclosureSEC source: 0001077183-19-000166 · wf-form4_156816191124916.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,676,233 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 21:10 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 1,200 | $25.00 | $30,000.00 |
DisclosureSEC source: 0001077183-19-000158 · wf-form4_156719943258551.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,677,924 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 28, 2019 Filed Aug 30, 2019 21:10 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 39,537 | $25.02 | $989,215.74 |
DisclosureSEC source: 0001077183-19-000158 · wf-form4_156719943258551.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,679,124 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 27, 2019 Filed Aug 27, 2019 21:40 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 30,280 | $24.95 | $755,486.00 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 7 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,718,661 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:40 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 143,603 | $24.87 | $3,571,406.61 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,748,941 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:40 UTC | NEOGENOMICS INC NEO · Entity 2096 | SaleCommon Stock | 7,456 | $25.72 | $191,768.32 |
DisclosureSEC source: 0001077183-19-000152 · wf-form4_156694199637576.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,892,544 F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:13 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantStock Option (Right to Buy) · Derivative | 4,269 | $0.00 Strike: $22.52 | $0.00 |
DisclosureSEC source: 0001077183-19-000106 · wf-form4_156021561175678.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,269 Underlying: Common Stock · 4,269 shares Expires 2026-06-06 Read SEC document |
| June 06, 2019 Filed Jun 11, 2019 01:13 UTC | NEOGENOMICS INC NEO · Entity 2096 | GrantCommon Stock | 3,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-19-000106 · wf-form4_156021561175678.xml · nonDerivative · entry 4 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,234 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.